Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Current Drug Targets. Inflammation and Allergy
|
August 17, 2005
Regulation of neutrophil apoptosis and removal of apoptotic cells
Annemieke Walker, Carol Ward, Emma L Taylor, et al.
British Journal of Pharmacology
|
May 29, 2003
Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis
Joanna Murray, Carol Ward, Joseph T O'Flaherty, et al.
Biochemical and Biophysical Research Communications
|
March 9, 2004
Golgi fragmentation during Fas-mediated apoptosis is associated with the rapid loss of GM130
Annemieke Walker, Carol Ward, Tara A Sheldrake, et al.
Biochemical Society Transactions
|
August 12, 2014
Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancer
Carlos Martinez-Perez, Carol Ward, Graeme Cook, et al.
Cancer Treatment Reviews
|
October 16, 2012
New strategies for targeting the hypoxic tumour microenvironment in breast cancer
Carol Ward, Simon P Langdon, Peter Mullen, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
The impact of tumour pH on cancer progression: strategies for clinical intervention
Carol Ward, James Meehan, Mark E Gray, et al.
Breast Cancer Research : BCR
|
January 24, 2019
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
Edward J Jarman, Carol Ward, Arran K Turnbull, et al.
European Journal of Immunology
|
January 29, 2002
Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis
Satoko Fujihara, Carol Ward, Ian Dransfield, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2012
Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines
Jean-Yves Winum, Fabrizio Carta, Carol Ward, et al.
BMC Cancer
|
June 6, 2018
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
Chrysi Xintaropoulou, Carol Ward, Alan Wise, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Current Drug Targets. Inflammation and Allergy
|
August 17, 2005
Regulation of neutrophil apoptosis and removal of apoptotic cells
Annemieke Walker, Carol Ward, Emma L Taylor, et al.
British Journal of Pharmacology
|
May 29, 2003
Role of leukotrienes in the regulation of human granulocyte behaviour: dissociation between agonist-induced activation and retardation of apoptosis
Joanna Murray, Carol Ward, Joseph T O'Flaherty, et al.
Biochemical and Biophysical Research Communications
|
March 9, 2004
Golgi fragmentation during Fas-mediated apoptosis is associated with the rapid loss of GM130
Annemieke Walker, Carol Ward, Tara A Sheldrake, et al.
Biochemical Society Transactions
|
August 12, 2014
Novel flavonoids as anti-cancer agents: mechanisms of action and promise for their potential application in breast cancer
Carlos Martinez-Perez, Carol Ward, Graeme Cook, et al.
Cancer Treatment Reviews
|
October 16, 2012
New strategies for targeting the hypoxic tumour microenvironment in breast cancer
Carol Ward, Simon P Langdon, Peter Mullen, et al.
Exploration of Targeted Anti-Tumor Therapy
|
September 1, 2022
The impact of tumour pH on cancer progression: strategies for clinical intervention
Carol Ward, James Meehan, Mark E Gray, et al.
Breast Cancer Research : BCR
|
January 24, 2019
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
Edward J Jarman, Carol Ward, Arran K Turnbull, et al.
European Journal of Immunology
|
January 29, 2002
Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis
Satoko Fujihara, Carol Ward, Ian Dransfield, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 23, 2012
Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines
Jean-Yves Winum, Fabrizio Carta, Carol Ward, et al.
BMC Cancer
|
June 6, 2018
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
Chrysi Xintaropoulou, Carol Ward, Alan Wise, et al.
Page
of 5